MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/djw171

Медицинская библиотека · Journal of the National Cancer Institute · 2016

Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.

Martens Milou H, Maas Monique, Heijnen Luc A, Lambregts Doenja M J, Leijtens Jeroen W A, Stassen Laurents P S, Breukink Stephanie O, Hoff Christiaan, Belgers Eric J, Melenhorst Jarno, Jansen Rob, Buijsen Jeroen, Hoofwijk Ton G M, Beets-Tan Regina G H, Beets Geerard L

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The aim of this study was to establish the oncological and functional results of organ preservation with a watch-and-wait approach (W&W) and selective transanal endoscopic microsurgery (TEM) in patients with a clinical complete or near-complete response (cCR) after neoadjuvant chemoradiation for rectal cancer.

METHODS

Between 2004 and 2014, organ preservation was offered if response assessment with digital rectal examination, endoscopy, and MRI showed (near) cCR. Watch-and-wait was offered for cCR, and two options were offered for near cCR: TEM or reassessment after three months. Follow-up included endoscopy and MRIs every three months during the first year, and every six months thereafter. Long-term outcome was assessed with Kaplan-Meier curves. Functional outcome was assessed with colostomy-free survival and Vaizey incontinence score (0 = perfect continence, 24 = totally incontinent).

RESULTS

One hundred patients were included, with median follow-up of 41.1 months. Sixty-one had cCR at initial response assessment. Thirty-nine had near cCR, of whom 24 developed cCR at the second assessment and 15 patients underwent TEM (9 ypT0, 1 ypT1, 5 ypT2). Fifteen patients developed a local regrowth (12 luminal, 3 nodal), all salvageable and within 25 months. Five patients developed metastases, and five patients died. Three-year overall survival was 96.6% (95% confidence interval [CI] = 89.9% to 98.9%), distant metastasis-free survival was 96.8% (95% CI = 90.4% to 99.0%), local regrowth-free survival was 84.6% (95% CI = 75.8% to 90.5%), and disease-free survival was 80.6% (95% CI = 70.9% to 87.4%). Colostomy-free survival was 94.8% (95% CI = 88.0% to 97.8%), with a good continence after watch-and-wait (Vaizey = 3.4, SD = 3.9) and moderate after TEM (Vaizey = 9.7, SD = 5.1).

CONCLUSIONS

Organ preservation appears oncologically safe for selected rectal cancer patients with a cCR or near cCR after neoadjuvant chemoradiation when applying strict selection criteria and frequent follow-up, including endoscopy and MRI. The low colostomy rate and the good long-term functional outcome warrant discussing this option with the patient as an alternative to major surgery.

Для цитирования: Martens Milou H, Maas Monique, Heijnen Luc A, Lambregts Doenja M J, Leijtens Jeroen W A, Stassen Laurents P S, Breukink Stephanie O, Hoff Christiaan, Belgers Eric J, Melenhorst Jarno, Jansen Rob, Buijsen Jeroen, Hoofwijk Ton G M, Beets-Tan Regina G H, Beets Geerard L. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.. Journal of the National Cancer Institute. 2016. DOI: 10.1093/jnci/djw171.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.